Spherix (SPEX)
Spherix Capital Expenditures: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SPEX Capital Expenditures Rankings
| Overall | 99th percentile | 1 of 4457 |
| Sector | 99th percentile | 1 of 508 in Healthcare |
| Industry | 96th percentile | 1 of 25 in Medical Laboratories & Research |
SPEX Capital Expenditures Range, Past 5 Years
| Minimum | 0.00 | Sep 2007 |
| Maximum | 0.15M | Jun 2008 |
| Average | 0.0115M |
About Capex
Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).
Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.
Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.
Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More
You may also be interested in these SPEX related companies
SPEX News
Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time
Apr 10, 11:05AM PR Newswire
Apr 10, 11:05AM PR Newswire
RT @idrinkchai $SPEX might holy grail here on intraday, what do you mean by that
about 86 days ago by allars
about 86 days ago by allars
Spherix (SPEX) Rips After Positive SPX-106T Data on Atherosclerotic Plaque Reduction
Mar 07, 10:19AM Street Insider
Mar 07, 10:19AM Street Insider
SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease
Mar 07, 9:15AM PR Newswire
Mar 07, 9:15AM PR Newswire
Spherix to Present at the LHA Life Sciences & Medical Technologies Virtual Conference on February 16
Feb 10, 10:42AM PR Newswire
Feb 10, 10:42AM PR Newswire
Spherix $SPEX Shares Halted on Breaker Down 22% Following $1.15M Offering
about 120 days ago by Street_Insider
about 120 days ago by Street_Insider
Spherix (SPEX) Shares Halted on Breaker Down 22% Following $1.15M Offering
Feb 02, 2:48PM Street Insider
Feb 02, 2:48PM Street Insider
Shares of Spherix Inc. (SPEX) Trade Up 40% on SPX-106 28-day Rat Toxicology Study Results
Jan 11, 11:51AM Street Insider
Jan 11, 11:51AM Street Insider
Spherix Announces Successful Completion of Important Toxicology Study of SPX-106
Jan 11, 9:47AM PR Newswire
Jan 11, 9:47AM PR Newswire
Spherix Issues Reminder of Business Update Conference Call Set for Today at Noon Eastern Time
Nov 16, 10:03AM PR Newswire
Nov 16, 10:03AM PR Newswire
$SPEX http://stks.co/9tx Showed they could reduce cholesterol levels in mice
about 266 days ago by Tr8r_x
about 266 days ago by Tr8r_x
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SPEX | 0.75 | -0.03 | -3.85% | 3.12M |
| SPCHB | 1.716 | +0.03 | +1.54% | 3.054M |
| SPCHA | 1.22 | -0.15 | -10.95% | 15.14M |
| SPBC | 12.85 | +0.00 | +0.00% | 22.23M |
| SPB | 33.15 | -1.37 | -3.97% | 1.787B |
| SPAR | 4.21 | -0.29 | -6.44% | 151.29M |
| SPAN | 17.51 | +0.01 | +0.06% | 51.10M |
| SPAB | 1.07 | +0.04 | +3.88% | |
| YGE | 2.71 | +0.11 | +4.23% | 378.53M |
| YELP | 15.59 | -1.12 | -6.70% |
